Fujifilm has been on the market for decades. Explain the company’s vision and commitment to provide its consumers with the best-in-class products and services in the marketplace.
Fujifilm has been a market leader since 1939. Since then, Fujifilm as a brand has firmly believed in driving innovation through values.
As a brand, we are dedicated to the constant development and introduction of new innovative technologies, products and services that strengthen the potential and broaden the horizons of future businesses and lifestyles. With cutting-edge, proprietary technologies initiated by an open, fair and clear corporate culture, our goal as a brand is to bring the best to people across all industries in which we are present and also to focus on serving society to serve to improve them with some of our initiatives.
What are the main goals of the brand? What is the most important industry for the brand and why?
Of all the industries we serve, Fujifilm’s medical division has contributed the most to the company’s growth in India. 60% of our turnover comes from the medical sector. We have expanded our portfolio to include CT scanners, MRI machines and ultrasound machines. Currently the company holds the first position with 50% market share for CR and Imager with over 55,000 installations across India. Our goal is to continue to grow the business to have a larger market share in these categories by further strengthening our endoscopy range and adding new products.
If healthcare is a significant contributor to the company’s business, what are some recent announcements/initiatives in that industry?
In the healthcare business, we continuously introduce several initiatives not only to increase brand visibility, but also to raise awareness of the timely detection of critical health issues and the importance of regular health check-ups.
With this in mind, we launched the “Nethe ver Stop: Screening to Reduce Diagnostic Delays” campaign to raise awareness of regular tuberculosis screening. As part of the campaign, we operated a mobile screening van in 27 cities in North India and screened over 721,000 people in the mobile van and shared a total of 8,104 x-ray reports in 6 months. The campaign is in line with the government’s goal of achieving a ‘TB-free India’ by 2025.
Additionally, we announced the opening of two NURA health screening centers in Gurugram and Mumbai in partnership with Dr. Kutty’s Healthcare to focus on early detection of cancer and lifestyle diseases in India. With the addition of these locations we are offering screening at a total of three NURA locations with the third being in Bangalore.
As a company, what contribution do you think Fujifilm is making with its CSR initiatives, particularly in healthcare as this is one of the key segments of the brand?
For us, CSR is one of our most important sectors. We have a strong focus on CSR initiatives to contribute and give back to society. Through our CSR, we strive to contribute to the sustainable development of society with our corporate philosophy through sincere and ethical business practices. Fujifilm’s main areas of focus for CSR initiatives worldwide and in India include education, environment and healthcare. We sincerely believe that education, environment and health care should be addressed with a humanitarian approach. Fujifilm’s Aao Padhai Karein and Aao Baat Karein initiatives aim to educate India’s young minds and develop a warm relationship with them. By 2030, we aim to contribute to government efforts to eliminate child sexual assault in India.
Healthcare is one of our most important business sectors and plays a significant role in our CSR initiatives. As a brand, we believe that a person can benefit society if they are healthy and disease-free, even if they are not actively involved in anything. Our commitment to serving the public and our financial acumen in the healthcare industry allow us to take that commitment even further.
To reinforce government efforts to eradicate TB in India and TB detection to District TB Officers in Kutch (Gujarat), Wayanad (Kerala) and Amguri (Assam) we have a Truenat machine in Kutch this year , 1 CB NAAT Machines donated in Waynad and 1 CBNAAT Machine in Amguri. Along with the equipment, we have also provided nutritional support through rice, salt, daal, gram (legumes) and oil to the most disadvantaged in society in Wayanad district of Kerala.
We have also worked with the Indian Cancer Society on their flagship program entitled Cancer Mukt Dilli. Emphasizing the importance of “early detection; Early Cure’, the campaign will reach out to people living in semi-rural villages in Delhi NCR and belonging to the economically disadvantaged sections of society. As part of this campaign, the company also provided financial support of Rs 1 lakh per year to healing cases. All of this was done to reinforce our goal of raising awareness of screening and supporting patients when needed.
In addition, we recently launched the second phase of our TB campaign “NEVER STOP: SCREENING TO REDUCE DIAGNOSTIC DELAYS” to raise awareness of TB as a curable disease and to promote screening and early diagnosis among workers in the tea sector. reach people in rural and urban areas, including tribal people in select districts of Gujarat, Kerala and Assam. In the first phase, we examined over a million people and shared around 8,000 X-ray reports. Through the intervention, 117 new TB patients were identified in 27 cities including Delhi, Dadri, Dehradun, Haridwar, Haldwani, Rudrapur, Patna, Jaipur, Indore, Kolkata, Raipur, Pata, etc.
Can you give us some details about the brand’s marketing strategy and recent campaigns?
For our health segment, we have launched several digital films to raise awareness of the importance of regular medical testing to eliminate the risk of chronic health conditions and to highlight the importance of timely health checks for people of all ages. The focus is entitled “Never Stop: Innovating for a healthier world”.
Recently, as part of Breast Cancer Awareness Month, we launched a new campaign with breast cancer survivors to raise awareness about breast cancer and the impact of the disease on a person’s health and the importance of regular checkups.
Additionally, we unveiled a campaign with Milin Sonam for the Instax camera line, titled ‘If You Can’t Print It, It’s Not Worth It’, which showcased how printed memories have the power to last a lifetime and always have feelings to evoke irrepressible joy and nostalgia at the reunion.
Where do you see Fujifilm as a brand in India in the next 5 years? What are the future growth and expansion plans – including new product launches and business expansion?
Fujifilm’s commitment to ‘never stop’ innovation for a better world encourages us as a brand to introduce eccentric technical innovations in every industry in which we operate. We will continue to powerfully evolve and add value to all our customers with cutting-edge technology in all our products and services in the market. With potential across all sectors, we expect the Indian business to post double-digit growth this fiscal year, driven primarily by the healthcare and consumer goods sectors.
Currently, our healthcare business – which includes X-ray imaging equipment, ultrasound systems, endoscopy systems, MRI and CT systems, and healthcare IT – contributes to more than half of Fujifilm’s Indian business. This segment is followed by another that includes Graphics & Printing, Photo Printing, Recording Media and Industrial Products, among others.
We assume that our instant camera segment will be the second largest contributor to sales after the healthcare segment in the next two years. As part of the expansion of our camera business, we aim to expand the portfolio of mirrorless cameras and introduce new models of the popular Instax series. We are also increasing the retail presence of the Instax series in both online and offline channels and expect to have around 2,000 retail outlets by the end of this year, up from the current 500.